LAUREN KERSCHER: Open Payments
NPI 1780931162 · MANHATTAN BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,013 in 116 payments from 21 companies in 2025. Trend: 2023 $1,947 · 2024 $2,028 · 2025 $3,013
Food & beverage: $2,263Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 4 | $809 |
| GENZYME CORPORATION | 16 | $496 |
| UCB, Inc. | 8 | $245 |
| Arcutis Biotherapeutics, Inc. | 4 | $214 |
| Botanix SB Inc | 9 | $208 |
| Incyte Corporation | 9 | $178 |
| MAYNE PHARMA COMMERCIAL LLC | 32 | $157 |
| ANI Pharmaceuticals, Inc. | 5 | $120 |
| Janssen Biotech, Inc. | 4 | $93 |
| PFIZER INC. | 4 | $80 |
Products named: DUPIXENT, Bimzelx, Zoryve, SOFDRA, OPZELURA, TREMFYA, CIBINQO, Veregen.
Industry payments across CA — which companies pay providers there.
